Skip to main content
Advocacy For Neuroacanthocytosis Patients
Accounts
| Year ended |
Net assets |
Cash |
Employees |
| 31 Aug 2025 |
£103,398 |
£34,763 |
1 |
| 31 Aug 2024 |
- |
- |
- |
| 31 Aug 2023 |
£81,863 |
£34,051 |
1 |
| 31 Aug 2022 |
£111,730 |
£112,999 |
1 |
| 31 Aug 2021 |
£37,739 |
£29,890 |
1 |
| 31 Aug 2020 |
£111,205 |
£111,805 |
1 |
| 31 Aug 2019 |
£89,309 |
£89,897 |
- |
| 31 Aug 2018 |
£33,793 |
£35,534 |
- |
| 31 Aug 2017 |
£31,637 |
£32,261 |
- |
| 31 Aug 2016 |
- |
- |
- |
| 31 Aug 2015 |
£105,385 |
£105,385 |
- |
| 31 Aug 2014 |
£72,597 |
£72,616 |
- |
| 31 Aug 2013 |
- |
- |
- |
| 31 Aug 2012 |
£60,770 |
£60,541 |
- |
| 31 Aug 2011 |
- |
- |
- |
| 31 Aug 2010 |
- |
- |
- |